Resultado de búsqueda
Anatomical and viability-guided completeness of revascularization were measured by the coronary and myocardial revascularization indices (RIcoro and RImyo) respectively, where RIcoro=[change in BCIS Jeopardy Score (BCIS-JS)] / [baseline BCIS-JS] and RImyo=[number of revascularized viable segments] / [ number of viable segments supplied by diseased vessels].
Ischemic cardiomyopathy. I25.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM I25.5 became effective on October 1, 2023. This is the American ICD-10-CM version of I25.5 - other international versions of ICD-10 I25.5 may differ.
1 de mar. de 2024 · Abstract. Treatment of ischemic cardiomyopathy has been the focus of increased attention by cardiologists due to recent evidence of an important outcome study comparing percutaneous coronary intervention (PCI) plus optimal medical treatment vs optimal medical treatment alone, concluding for the futility of myocardial revascularization by PCI.
24 de oct. de 2023 · More recently, the revascularization for ischemic ventricular dysfunction (REVIVED-BCIS2) study enrolled 700 subjects presenting with an LVEF ≤ 35%, extensive CAD—defined by a British Cardiovascular Intervention Society jeopardy score ≥ 6, and confirmed viability in a minimum of four dysfunctional myocardial segments, suitable for percutaneous revascularization [24••].
To characterize cardiomyopathy as ischemic, a BCIS-Jeopardy score4 ≥ 6 was required, with 49% of the patients having 2-vessel disease, while the median number of lesions and vessels treated per patient in the PCI group was 2, and complete revascularization was achieved in 71% of the patients.1
functional, or ischemic parameters, or a combination. •If CR is not achieved, the degree of anatomic incomplete revascularization (ICR) can be quantified by the residual SYNTAX score (rSS) or the residual jeopardy score. These metrics of ICR have been shown to be associated with adverse clinical outcomes.1
12 de sept. de 2023 · inclusion in the trial if they had ischemic left ventricular dys-function, defined by the presence of severe left ventricular systolic dysfunction (left ventricular ejection fraction ≤35%), extensive coronary disease (British Cardiovascular Intervention Society Jeopardy Score ≥6), and evidence of viability in at least
